Posted in | News | Nanobusiness

LDK Solar Announces Acquisition of a Controlling Interest of Solar Green Technology

LDK Solar Co., Ltd. (NYSE:LDK), a leading manufacturer of multicrystalline solar wafers, which are the principal raw material used to produce solar cells, today announced the acquisition of a controlling interest of Solar Green Technology S.p.A. ("SGT"), one of the most experienced Italian system integrators of turnkey PV plants.

LDK Solar acquired 70% of Solar Green Technology S.p.A.'s shares. This investment will boost LDK Solar's efforts to develop additional projects and strengthen its presence in the Italian PV sector. SGT will provide project opportunities and technical support in terms of realization and control of PV turnkey plants to LDK Solar.

"We are very excited to acquire a controlling interest of Solar Green Technology," stated Xiaofeng Peng, Chairman and CEO of LDK Solar. "SGT's management and workforce have demonstrated strong competence and boasts solid experience in the PV market. We believe access to SGT's wealth of resources will be an effective and immediate tool for LDK Solar efforts in managing development activity in the Italian PV market, which is currently one of the most dynamic and profitable European markets."

"We are pleased to have LDK Solar acquire a majority interest of SGT," commented Giuseppe Truglio, one of the Solar Green Technology's founders. "This investment will enable SGT to grow rapidly through its involvement in several of LDK Solar's important plant projects in Italy and throughout Europe. Given the current development stage of the Italian PV market, we are excited to increase our exposure in such a profitable and promising market."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.